Cladribine

Overview

Cladribine is a chemotherapeutic agent used for the treatment of hairy cell leukemia and as an immunosuppressive agent in multiple sclerosis. It works by interfering with the growth of certain white blood cells, which helps in reducing the proliferation of cancer cells.

API suppliers (11)

Suppliers of Cladribine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• RELIABLE BIOPHARMACEUTICAL CORP1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• RELIABLE BIOPHARMACEUTICAL CORP1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• RELIABLE BIOPHARMACEUTICAL CORP1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• RELIABLE BIOPHARMACEUTICAL CORP1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• CILAG AGSwitzerland
• AXITEC CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Cladribine expires 9 Sept 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas